Fall 2009

Fall 2009

Cancer Center Seminar Series

Fall 2009 Schedule 

Fridays 12:30-1:30pm
McKim Hall Auditorium, unless otherwise noted

The UVA Cancer Center presents this seminar series.  Refreshments will be served outside McKim Auditorium beginning at 12:00.

Please note, the Seminar Series is not being offered for CME credit.

August   September   October   November    December


Aug 7, 2009

Seminar will be in Jordan 1-17
John H. Sampson, M.D., Ph.D., Duke University Medical Center, Department of Surgery/Neurosurgery, Durham, N.C.
Advancing Tumor-specific Immunotherapy to the Holy Grail of Big Pharma and Beyond...!

Host: Roger Abounader, M.D., Ph.D.,
Depts of Neurology and Microbiology

Jordan 1-17


Sept 18, 2009
Deborah Lannigan, Ph.D., Associate Professor, Department of Microbiology and Center for Cell Signaling
High RSK is High Risk for Cancer?
 Host: Sally Parsons, Ph.D., Dept of Microbiology
McKim Aud

Sept 25, 2009 Ronald C. Hendrickson, Ph.D., Head of Proteomics, Molecular Profiling, Merck Research Laboratories, Rahway, NJ
Proteomics: An Integral Part of Merck's Strategy for Biomarker Discovery and New Target Identification
Host: Don Hunt, Ph.D., Depts of Chemistry & Pathology
McKim Aud

Oct 2, 2009
Anindya Dutta, M.D., Ph.D., Professor, Departmentst of Biochemistry & Molecular Genetics and Pathology
Ultra-Highthroughput Sequencing of RNA or DNA in Cancer Biology
Host: Sally Parsons, Ph.D., Dept of Microbiology
McKim Aud

Oct 9, 2009
John H. Bushweller, Ph.D., Professor of Molecular Physiology and Biological Physics, Professor of Chemistry
Structural and Chemical Biology Approaches to Understanding and Treating Leukemia
Host: Sally Parsons, Ph.D., Dept of Microbiology
McKim Aud

Oct 16, 2009 Joyce L. Hamlin, Ph.D., Professor and Chair, Department of Biochemistry & Molecular Genetics
Regulating and Disregulating Origins of Replication in Normal and Tumor Cells
Host: Sally Parsons, Ph.D., Dept of Microbiology

McKim Aud


Oct 23, 2009
Mien-Chie Hung, Ph.D., Professor and Chairman of Molecular and Cellular Oncology, Director, Breast Cancer Basic Research Program, University of Texas MD Anderson Cancer Center, Houston, TX
To Believe or Not to Believe: Novel Functions of EGF Receptor
Host: Sally Parsons, Ph.D., Dept of Microbiology
McKim Aud

Oct 30, 2009 Amy P. Abernethy, M.D., Program Director, Duke Cancer Care Research Program, Cancer Control Program Associate Director, Duke Comprehensive Cancer Center, Medical Director, Oncology Quality, Outcomes, and Patient-centered Care, Duke University Health System
Cancer Symptom Management: A Systematic Approach to Evidence Development and Implementation
Host: Paul Read, M.D., Ph.D., Dept of Rad Onc McKim Aud

Nov 6, 2009
Sylvia Adams, M.D., Assistant Professor of Medicine, Langone Medical Center, New York University, New York, NY
Clinical investigation of Dendritic Cells, Montanide and Toll-like Receptor Agonists as Cancer Vaccine Adjuvants
Host: David Mullins, Ph.D., Dept of Microbiology McKim Aud

Nov 13, 2009 Jordan 1-17, 12:15-1:15
Craig L. Slingluff, Jr., M.D., Professor, Department of Surgical Oncology, Vice-Chair for Research, Director, Human Immune Therapy Center
Immunologic and Regulatory Effects of Cancer Vaccine Adjuvants Systemically and at the Vaccine Site
Host: Sally Parsons, Ph.D., Dept of Microbiology
Jordan 1-17

Nov 20, 2009 Jedd D. Wolchok, M.D., Ph.D, Melanoma Sarcoma Oncology, Memorial Sloan-Kettering Cancer Center
Clinical and Correlative Immunologic Results of CTLA-4 Blockade in Melanoma
Host: Tim Bullock, Ph.D., Dept of Pathology
McKim Aud

Dec 4, 2009 David L. Brautigan, Ph.D., Professor of Microbiology and Internal Medicine, Director, Center for Cell Signaling
Ancient Protein Phosphatase Regulation of Centrosomes, Chromosomes, and Cilia
Host: Sally Parsons, Ph.D., Dept of Microbiology
McKim Aud

Dec 11, 2009
Sarah E. Aiyar, Ph.D., Instructor, Department of Medicine, Endocrinology and Metabolism
Combination Therapy for Treatment of Metastatic Breast Cancer 
Host: Peggy Shupnik, Ph.D., Dept of Medicine
McKim Aud

Dec 18, 2009
Michael Douvas, M.D., Disivion of Hematology/Oncology and Fellow, Mark Prichard, M.D., Division of Hematology/Oncology
Therapeutic Implications of Variant Philadelphia Chromosome Translocations in CML and ALL
Host: Sally Parsons, Ph.D., Dept of Microbiology  McKim Aud

Back to Top Seminar Series Home